NCT04793646View on ClinicalTrials.gov

N-acetylcysteine for Primary Sjögren's Syndrome

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 30, 2021

Primary Completion Date

December 31, 2024

Study Completion Date

January 21, 2025

Conditions
Sjögren SyndromeSicca Syndrome
Interventions
DRUG

N-acetylcysteine syrup

N-acetylcysteine syrup 600 mg (15 mL) twice a day for 3 months

DRUG

Placebo syrup

Placebo syrup 15 mL twice a day for 3 months

Trial Locations (2)

05403-000

Hospital das Clinicas da Faculdade de Medicina da USP, São Paulo

Rheumatology Division of Hospital das Clínicas da Faculdade de Medicina da Universidade de Sao Paulo, São Paulo

All Listed Sponsors
lead

University of Sao Paulo General Hospital

OTHER